| Raymond J Rybicki, MD | |
|
7401 104th Ave Ste 110, Kenosha, WI 53142-7845 | |
| (262) 764-5595 | |
| (262) 764-9314 |
| Full Name | Raymond J Rybicki |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 43 Years |
| Location | 7401 104th Ave Ste 110, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932170180 | NPI | - | NPPES |
| 30742300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 27496020 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comprehensive Orthopaedics Sc | 3375445497 | 19 |
News Archive
As rates of skin cancer, or melanoma, rise for men and women in the United States, health experts are debating the effectiveness of annual total body examinations in helping to detect the disease in its earlier stages.
Researchers have found that a programme of cognitive behaviour therapy delivered by nurses to children who had asthma and anxiety improved the children's quality of life scores and reduced the risk of escalation of treatment.
Biomerix Corporation, a medical technology company developing and manufacturing innovative hernia repair products, today announced that it has entered into an exclusive distribution agreement with Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical and surgical products in the United States.
An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had open surgery.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted its complete response to the Complete Response (CR) letter issued by the U.S. Food & Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) for azficel-T, proposed brand name laViv®, for the treatment of moderate to severe nasolabial folds and wrinkles.
› Verified 7 days ago
| Entity Name | Comprehensive Orthopaedics Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295717445 PECOS PAC ID: 3375445497 Enrollment ID: O20040121000174 |
News Archive
As rates of skin cancer, or melanoma, rise for men and women in the United States, health experts are debating the effectiveness of annual total body examinations in helping to detect the disease in its earlier stages.
Researchers have found that a programme of cognitive behaviour therapy delivered by nurses to children who had asthma and anxiety improved the children's quality of life scores and reduced the risk of escalation of treatment.
Biomerix Corporation, a medical technology company developing and manufacturing innovative hernia repair products, today announced that it has entered into an exclusive distribution agreement with Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical and surgical products in the United States.
An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had open surgery.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted its complete response to the Complete Response (CR) letter issued by the U.S. Food & Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) for azficel-T, proposed brand name laViv®, for the treatment of moderate to severe nasolabial folds and wrinkles.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Raymond J Rybicki, MD 7401 104th Ave Ste 110, Kenosha, WI 53142-7845 Ph: (262) 764-5595 | Raymond J Rybicki, MD 7401 104th Ave Ste 110, Kenosha, WI 53142-7845 Ph: (262) 764-5595 |
News Archive
As rates of skin cancer, or melanoma, rise for men and women in the United States, health experts are debating the effectiveness of annual total body examinations in helping to detect the disease in its earlier stages.
Researchers have found that a programme of cognitive behaviour therapy delivered by nurses to children who had asthma and anxiety improved the children's quality of life scores and reduced the risk of escalation of treatment.
Biomerix Corporation, a medical technology company developing and manufacturing innovative hernia repair products, today announced that it has entered into an exclusive distribution agreement with Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical and surgical products in the United States.
An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had open surgery.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has submitted its complete response to the Complete Response (CR) letter issued by the U.S. Food & Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) for azficel-T, proposed brand name laViv®, for the treatment of moderate to severe nasolabial folds and wrinkles.
› Verified 7 days ago
Dr. Pushparanee Babusukumar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3535 30th Ave, Suite 201, Kenosha, WI 53144 Phone: 262-652-7813 Fax: 262-652-4450 | |
Dr. Jimmy Viet Ninh, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-7815 | |
Dr. Mathew Sean Mccarthy, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3536 52nd St, Kenosha, WI 53144 Phone: 262-657-1090 | |
Dr. Saritha Kundoor, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Anna Klyachkina, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12225 71st St, Kenosha, WI 53142 Phone: 262-948-4870 | |
Dr. Vanessa Q Chang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, #307, Kenosha, WI 53142 Phone: 262-948-6770 | |
Ronald Rubin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3734 7th Ave Ste 12, Kenosha, WI 53140 Phone: 262-654-9370 Fax: 262-654-9379 |